According to Zhitong Finance App News, Antu Biotech (603658.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 3.24 billion yuan, up 3.59% year on year; net profit attributable to shareholders of listed companies was 847 million yuan, down 1.45% year on year; after deducting non-net profit of 828 million yuan, up 1.52% year on year; basic earnings per share were 1.48 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.